Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha-1 beta-gamma subtype (GABA_A receptor α1βγ)

Target
GABA_A receptor α1βγ
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family, Receptor
01

Overview

The Gamma-aminobutyric acid type A (GABA_A) receptor alpha-1 beta-gamma subtype is a pentameric ligand-gated ion channel that serves as the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system (Olsen & Sieghart, 2008). This specific subtype, typically composed of α1, β2/3, and γ2 subunits, is the most prevalent GABA_A receptor isoform in the brain, particularly concentrated in the cerebral cortex, hippocampus, and cerebellum (Sigel & Steinmann, 2012). It functions by conducting chloride ions across the neuronal membrane upon GABA binding, leading to hyperpolarization and decreased neuronal firing. The α1-containing receptors are notably characterized by their high affinity for benzodiazepines and non-benzodiazepine hypnotics (Z-drugs), which bind at the α1-γ2 subunit interface (Tan et al., 2011). Pharmacological targeting of this subtype is central to the treatment of insomnia and epilepsy, as it mediates the sedative, hypnotic, and anticonvulsant properties of these agents (Rudolph & Knoflach, 2011). However, chronic modulation can lead to side effects such as tolerance, dependence, and cognitive impairment.

Other names
GABRA1-containing GABA_A receptorBenzodiazepine receptor type 1BZ1 receptorGABA(A) receptor alpha-1 subunit-containing complex
02

Mechanism of action

Positive allosteric modulation of the GABA-A receptor, which increases the frequency of chloride channel opening in response to GABA binding, thereby enhancing inhibitory postsynaptic potentials (Sigel & Steinmann, 2012).

03

Biological functions

Inhibitory neurotransmissionChloride ion transportNeuronal hyperpolarizationRegulation of neuronal excitability
04

Disease associations

InsomniaEpilepsyAnxiety disorderSeizure disorderAlcohol withdrawal
05

Safety considerations

SedationPhysical dependenceToleranceWithdrawal syndromeCognitive impairmentAnterograde amnesiaRespiratory depression in overdose
06

Interacting drugs

Zolpidem

7 more in the full profile.

07

Biomarkers

Electroencephalography (EEG) beta power[11C]flumazenil Positron Emission Tomography (PET) bindingSaccadic eye movement velocity

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha-1 beta-gamma subtype (GABA_A receptor α1βγ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-1 beta-gamma subtype (GABA_A receptor α1βγ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call